Phathom Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Phathom Pharmaceuticals

28/02/2023 13:53

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of $1.33​​ per share for the quarter ended in
December. The mean expectation of six analysts for the quarter
was for a loss of $1.35 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $1.33​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Phathom Pharmaceuticals Inc shares had fallen by 13.5%
this
quarter.
    * The company reported a quarterly loss of $55.05 million.
    * Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is $22.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 01:53 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.35          -1.33          Beat
 Sep. 30 2022      -1.32          -1.32          Met
 Jun. 30 2022      -1.03          -1.33          Missed
 Mar. 31 2022      -0.97          -1.07          Missed